Results 241 to 250 of about 447,696 (288)

Harmonization of IgG antibody values against the SARS-CoV-2 Spike protein. [PDF]

Sci Rep
Saraiva AL, Afreixo V, Amaral P, Viana JF, Antunes I, Paiva A, Gonçalves LA, Araújo L, Machado A, Gaio V.   +9 more
europepmc   +1 more source

Anti-GIP antibodies and future diabetes related risk: an eight-year prospective cohort study. [PDF]

Front Endocrinol (Lausanne)
Hashimoto T, Ohtake N, Okamoto T, Zhang BS, Yoshida Y, Takizawa H, Yamaga M, Yoshida T, Kajiyama A, Yagihashi T, Furukawa R, Hiwasa T, Takemoto M.   +12 more
europepmc   +1 more source

Real-world immune dynamics following COVID-19 vaccination and breakthrough infection: a paired-sample study in Zhejiang Province, China. [PDF]

Front Immunol
Hu Y, Weng Y, Li X, Huang Y, Pan J, Wu Y, Liao R, Gong R, Zhao L, Zhang D, Han M, Xu Y, Zheng X, Lu S, Kong Q, Chen E.   +15 more
europepmc   +1 more source

Antibody-drug conjugates in cancer therapy: do we need biomarkers? A comprehensive review. [PDF]

Cancer Metastasis Rev
Lei L, Zheng YB, Tang SC.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody

Histopathology, 1994
The reactivity of MIB1 antibody on routinely processed paraffin sections was compared with that of Ki-67 antibody on frozen sections of 80 transitional cell carcinomas of the bladder. The percentage of labelled cells was expressed as the labelling index.
J Selves, G Delsol, Zivko Popov
exaly   +3 more sources

Natalizumab in MS: JC antibody index

Journal of Neurology, 2015
N P Robertson
exaly   +3 more sources